Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP) (Q24239940)

1

0 references

Sauwalak Opastirakul

2

0 references

Elisabeth M Hodson

3

0 references

Narelle S Willis

Cochrane Database of Systematic Reviews

4

0 references

publication date

8 July 2009

0 references

published in

0 references

cites work

A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Prophylaxis and therapy of glomerulonephritis in the course of anaphylactoid purpura. The results of a polycentric clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Evidence-based assessment of treatment options for children with IgA nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Therapy for children with henoch-schonlein purpura nephritis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Interventions for preventing and treating renal disease in Henoch-Schönlein Purpura (HSP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

Long term renal prognosis of Henoch-Sch�nlein Purpura in an unselected childhood population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

7 January 2021

Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

7 January 2021

Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

7 January 2021

Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

7 January 2021

Multiple combined therapy for severe Henoch-Schönlein nephritis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

7 January 2021

Long-term follow-up of childhood Henoch-Schönlein nephritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

7 January 2021

Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

7 January 2021

Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005128.PUB2

7 January 2021